Business
Ocumetics Reports Second Successful Surgery Day
(TheNewswire) Calgary, Alberta – TheNewswire - September 26, 2025 - Ocum...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Reports Second Successful Surgery Day\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n September 26, 2025\n \n\n -\nOcumetics Technology Corp\n \n\n .\n \n\n (“Ocumetics” or the “Company”)\n(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced\nophthalmic technology, is pleased to announce that the Company\nsuccessfully completed its second surgical day in Mexico City as part\nof its ongoing clinical study evaluating the Ocumetics Accommodating\nIntraocular Lens (the “Ocumetics Lens”).\n \n\n\n\n All procedures were completed safely and without any\nreported issues or complications. These results further strengthen\nconfidence in both the safety profile of the Ocumetics Lens and the\nsurgical protocol designed to evaluate its performance. Group 1\npatient surgeries are now completed.\n \n\n\n\n Dean Burns, President and CEO of Ocumetics,\ncommented “We are thrilled with the success of our second surgical\nday. The momentum we are building in this program gives us great\nexcitement as we move forward in our clinical journey.”\n \n\n\n\n The Company has not yet received all data from the\none-month postoperative examinations of Group 1, Day 1 patients. An\nupdate will be provided when the one-month post operative results\nbecome available.\n \n\n\n\n The Company’s first-in-human clinical protocol was\nstrategically designed to address three patient groups. The endpoints\nfor each group are focused on the following key areas of\nevaluation:\n \n\n\n\n Primary endpoints:\n \n\n\n\n • Safety - establishing a clear baseline of patient\nhealth and recovery\n \n\n\n\n • Distance vision correction - assessing the\nOcumetics Lens’s ability to restore far vision\n \n\n\n\n Secondary endpoints:\n \n\n\n\n • Product handling and surgical delivery - ensuring\nprocedural efficiency and reliability\n \n\n\n\n • Near reading ability - evaluating the Ocumetics\nLen’s ability to restore close-range vision\n \n\n\n\n About Ocumetics\n \n\n\n\n Ocumetics Technology Corp.\n \n\n (\n \n\n TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)\nis a Canadian research and product development company that\n \n\n is dedicated to developing advanced vision\ncorrection s...